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Functional magnetic resonance imaging (fMRI) has provided the opportunity to safely investigate the workings of the human
brain. This paper focuses on its use in the field of human appetitive behaviour and its impact in obesity research. In the present
absence of any safe or eﬀective centrally acting appetite suppressants, a better understanding of how appetite is controlled is vital
for the development of new antiobesity pharmacotherapies. Early functional imaging techniques revealed an attenuation of brain
reward area activity in response to visual food stimuli when humans are fed—in other words, the physiological state of hunger
somehow increases the appeal value of food. Later studies have investigated the action of appetite modulating hormones on the
fMRI signal, showing how the attenuation of brain reward region activity that follows feeding can be recreated in the fasted state by
the administration of anorectic gut hormones. Furthermore, diﬀerences in brain activity between obese and lean individuals have
provided clues about the possible aetiology of overeating. The hypothalamus acts as a central gateway modulating homeostatic and
nonhomeostatic drives to eat. As fMRI techniques constantly improve, functional data regarding the role of this small but hugely
important structure in appetite control is emerging.
1. Introduction
When energy intake exceeds energy expenditure in the long
term, the excess accumulates as body fat. It is predicted
that, by 2015, as many as 30% of adults in Europe will be
obese, as defined by a body mass index (BMI) ≥30 kg/m2
[1]. It is well known that obesity confers increased risk to a
range of diseases, including type 2 diabetes, cardiovascular
disease, and cancer. An enhanced understanding of the
physiological mechanisms that regulate appetite is essential
for the development of pharmacological strategies to combat
obesity. In particular, within the field of neuroendocrinology,
identification of hormone-brain interactions that modulate
appetite (and subsequent food intake) will aid the manip-
ulation of naturally occurring hormones to develop safe
and eﬀective antiobesity therapies. This strategy, exploiting
physiological pathways of appetite control, holds promise for
the future treatment of obesity, especially given the shortage
of eﬀective pharmacotherapies for obesity in the existing
market. For a comprehensive overview of the position of gut
hormones in the treatment of obesity, we direct the reader to
a review by Valentino et al., 2010 [2].
The control of appetite and food intake can be divided
into “homeostatic” and “nonhomeostatic” control. The
alteration in consumption of food that follows sensing of
energy balance forms the basis of the homeostatic control of
appetite: following a meal, appetite is suppressed, whereas,
following significant energy expenditure, we feel hungry.
Postprandial satiety signals include changes in circulating
concentrations of nutrients and gut hormones. These include
the anorectic hormones PYY and GLP-1 and the orexigenic
hormone ghrelin [3], as well as activation of somatosensory
vagal aﬀerents conveying information such as gastric disten-
sion [4]. Adipokines (hormones secreted by adipose tissue,
such as leptin) convey information to the CNS about longer-
term energy stores [5]. Furthermore, it is well established
that insulin is secreted acutely from the pancreas in response
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to a glucose load but is also basally elevated in states of
overnutrition and obesity, thereby implying a role in con-
veying both short- and longer-term information regarding
energy balance. In normal physiology, the integration of the
above inputs within central neural appetite circuits results
in appropriately matching food intake to metabolic need.
The hypothalamus is widely recognised as the gatekeeper
for this processing task, in line with other important
homeostatic functions controlling body temperature, energy
expenditure, and glucose metabolism. In keeping with this,
there is mounting evidence that hypothalamic dysfunction is
implicated in the pathogenesis of obesity [6].
With regard to “nonhomeostatic” control, food intake is
driven by factors including food palatability (incorporating
the key senses of sight, smell, and taste), habitual, socio-
cultural, emotional, and economic influences. From an
emotional perspective, the evaluation of a food stimulus for
its motivational significance occurs inmultiple brain regions,
particularly the dopaminergic limbic and prefrontal reward
areas [7]. Key areas include the amygdala, hippocampus,
insula, striatum, and orbitofrontal cortex (OFC), although
this list is by no means exhaustive. It is now widely
accepted that, with regard to appetite control, homeostatic
and nonhomeostatic systems do not function independently;
instead, there is extensive cross-modulation between them,
along with a complex integration of inputs before a final
decision is made regarding food consumption (Figure 1).
Over the past decade, functional magnetic resonance
imaging (fMRI) has become a popular and rapidly advancing
tool for investigating CNS appetite pathways in humans,
oﬀering the key advantage of avoiding exposure to ionising
radiation. Following on from previous similar articles [8–
10], here we provide an updated review of recent advances in
our understanding of human appetitive behaviour based on
the results of fMRI studies. We start with a brief overview of
the technique and then summarise findings from the earliest
fMRI appetite studies, which first explored diﬀerences in
brain activation patterns between the normal fed and fasted
state and in response to glucose ingestion. This is followed
by a discussion of a further cluster of studies, exploring
diﬀerences between obese and lean populations. Finally, we
review the results of fMRI studies investigating hormonal
influences on appetitive brain processes and in relation to
this and explore recent functional neuroimaging outcomes
following intervention in obese subjects.
2. Principles of fMRI in Appetite Studies
A full description of fMRI methodology is clearly outside
the remit of this paper. It is nevertheless useful for the non-
imaging specialist to understand some of the technicalities of
fMRI, in order to gain a better appreciation of how the field
has progressed, as well as some of its limitations.
MRI utilises the behaviour of hydrogen nuclei, which
consist of single protons that possess angular momentum
(spin). As soon as an external magnetic field (B0) is applied,
the protons in tissue tend to align with this, causing their
spins to precess about a circular path around B0. Here, they
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Figure 1: Brain reward centres: the hypothalamus (H), as a
homeostatic gatekeeper, has numerous connections with higher
brain centres which process salience and reward. The hypothalamus
transmits to these higher centres information received from the
periphery, such as nutritional status signalled via the postprandial
release of gut hormones, and in turn modulates metabolic rate via
the sympathetic nervous system. This sagittal section of the brain
reveals the important areas involved in the hedonic control of eating
behaviour; amygdale (Am): emotional and aversive processing;
nucleus accumbens (Nac): anticipatory reward processing; ventral
tegmental area (VTA): numerous dopaminergic projections to
other limbic areas; ventral striatum (VS): motivation reward;
expectancy and novelty processing; anterior cingulate cortex (ACC):
decision making; orbitofrontal cortex (OFC): reward encoding;
prefrontal cortex (PFC): translation of external and internal cues
into behavioural responses; dorsolateral prefrontal cortex (DLPFC):
self-control. Not shown is the insular cortex (a more lateral
structure), which is also important in gustatory processing.
are in a low-energy state. Generation of MRI images requires
application of a radiofrequency (RF) pulse at 90 degrees to
B0. The protons will then “tip” to align with the RF pulse. In
doing so, they gain energy. After the RF pulse is switched oﬀ,
the protons realign with B0. Spins return to the low-energy
state by emitting the absorbed energy, also in the form of
a radio wave. The emitted energy can be measured by the
receiver coil and converted to images. By slightly altering the
strength of the magnetic field (and therefore the frequency
of the emitted radiation) using gradient coils across the
volume to be imaged, spatial information can be inferred.
The T1 relaxation time is a time constant referring to the
realignment of spins with B0 in the longitudinal plane after
the RF pulse is switched oﬀ. The T2 relaxation time, on the
other hand, is a time constant referring to the dephasing of
spins in the transverse plane after the RF pulse is switched
oﬀ (Figure 2). T1 and T2 vary depending on the tissue being
imaged. The strength of magnetic resonance signal obtained
for a particular tissue depends primarily on the proton
density. However, by altering the time between successive RF
pulses and therefore the degree of T1 and T2 relaxation, the
image can be weighted towards one or the other of these
tissue-specific properties. It should be noted that, in practice,
due to localised inhomogeneities in the externally applied
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Figure 2: Schematic of T1 and T2 relaxation. MRI utilises the behaviour of protons within varying magnetic fields to produce signals which
can be converted into images. Each hydrogen nucleus in the brain can be thought of as a vector (in the z and x-y planes) representing the
strength and direction of its magnetic field as it spins on its axis (its magnetic dipole moment, MDM). The MDMs of the imaged protons
try to align with the main external magnetic field of the scanner (referred to here as B0 and conventionally shown along the z axis in 3D
coordinates). A secondmagnetic field (in the form of a short radiofrequency RF pulse) is applied, which flips all of theMDMs from alignment
in the z direction into the x-y plane (a). Before application of the RF pulse the, amplitude in the z-axis is maximal while the amplitude in
the x-y plane is zero. Just after application of the RF pulse the, amplitude in the z-axis is zero (a) while the amplitude in the x-y plane is
maximal (d). During relaxation, the amplitude in the z-axis will slowly increase ((b) and (d)) while the amplitude in the x-y plane slowly
decreases ((e) and (f)). T1 relaxation is the time taken for the z vector to regain in strength, whereas T2 relaxation is the time taken for the
x-y vector to decay. These changing magnetic vectors invoke their own RF signals, which are picked up by the receiver coils and interpreted
into information about the proton density of the subject being scanned.
magnetic field, T2 is shorter than expected for any particular
tissue. This apparent T2 is referred to as T2
∗.
fMRI utilises adaptations of this classical MRI technique,
such that function of tissues can be analysed rather than
structure alone. Virtually, all fMRI studies rely on a measure
called blood-oxygenation-level-dependent (BOLD) contrast,
based on the fact that oxygenated and deoxygenated blood
possess diﬀerent magnetic properties. Increased neuronal
activity in the brain elicits a local haemodynamic response,
which causes an increase in blood flow greater than necessary
for tissue demands. This results in a locally reduced ratio
of deoxyhaemoglobin to oxyhaemoglobin concentrations,
and the ensuing diﬀerences in local magnetic field inhomo-
geneities can be detected on a T2
∗-weighted imaging proto-
col [11, 12]; the locally reduced ratio of deoxyhaemoglobin
to oxyhaemoglobin leads to a longer T2
∗, producing an
increased image intensity. Such protocols typically use
magnetic gradients to generate the MR signal (gradient-echo
imaging) and, as scanner and computational hardwares have
advanced, faster sequences have been developed to acquire
large numbers of images in short spaces of time. Echo-
planar imaging (EPI), for example, is a technique whereby
an entire 2-dimensional image can be attained by the rapid
alteration of spatial gradients following a single RF pulse. In
this way, the entire brain can now be functionally imaged
within the same timeframe as the physiological changes of
interest. FunctionalMRI has thus provided hugely important
insights in numerous disciplines. However, its use in the field
of neuroendocrinology has been limited due to the inherent
weakness of the technique at imaging the hypothalamus. This
small (approximately 5–8mm in diameter) brain structure
lies close to the air-tissue boundaries of surrounding sinuses
and is susceptible to signal loss due to resultant distortions
of the external magnetic field, which is a particular issue for
T2
∗-weighted images as already described [13].
fMRI image reconstruction results in the selected brain
area divided into thousands of voxels, each assigned a signal
intensity. Statistical analysis of each voxel or cluster of voxels
ascertains whether the signal intensity there is greater than
compared with all others. Whilst this approachmay be useful
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for exploratory studies, most fMRI experiments perform
ROI (region of interest) analyses whereby the functional
properties of a predetermined set of voxels (corresponding
to a priori anatomical areas of the brain) are analysed.
ROI analysis, with very many fewer degrees of freedom
than whole-brain voxelwise analysis, has a greater chance
of finding statistically significant results but entails the
inherent risk of missing activated areas of the brain that
were not included in the original hypothesis. Resting state
functional connectivity analyses investigate the activational
interrelationships between diﬀerent brain regions, allowing
for the formation of distinct neuronal networks implicated
in a coordinated brain response [14]. Resting state scans
are performed when the subject is not performing any
purposeful task and have recently reported on blood flow
to the hypothalamus as an ROI with or without infusion of
anorectic gut hormones [15].
Another commonly used approach in the area of func-
tional imaging of appetite is to present the subject with
images of food (with further subdivision into appetising,
bland, high calorie, or low calorie food) or nonfood items.
A subtraction analysis is performed to see whether the dif-
ference in regional brain activation between viewing images
of food or nonfood is altered in diﬀerent physiological
conditions (e.g., the fasted state, the fed state, or in the
presence of exogenously administered anorectic hormones).
Several studies have utilised this approach; these will be
discussed in depth subsequently. Hypothalamic data remain
an elusive goal with such whole brain task-based analyses; in
addition to the aforementioned diﬃculties in hypothalamic
imaging, activation of some nuclei within the hypothalamus
promotes food intake, whereas other nuclei are appetite-
inhibiting [16]. Therefore, using the hungry, fasted state as an
example, the overall hypothalamic signal resulting from the
activation of orexigenic nuclei and inhibition of anorexigenic
nuclei may in fact be negligible, due to the above opposing
signals cancelling each other out. In addition to developing
stronger magnetic fields to enhance spatial resolution, newer
perfusion imaging techniques, which are T1 weighted, may
provide better hypothalamic data which is not so aﬀected
by signal loss due to magnetic susceptibility artefacts [17].
Arterial spin labelling (ASL) uses RF pulses to magnetically
label protons in blood water molecules before they reach the
tissue of interest which lies in the imaging plane from where
data is acquired.
3. Imaging the Hypothalamic Response to
Glucose Using Midsagittal Slice Selection
Early studies that have concentrated on hypothalamic signal
change involved conventional T2
∗-weighted gradient-echo
MRI pulse sequences to functionally scan a sagittal plane
through the hypothalamus continuously, acquiring images
before- and after- a given stimulus. By concentrating all
image processing ability on this thin, central slice, greater
attention can be devoted to a ROI corresponding to the
hypothalamus, although clearly at the expense of imaging the
rest of the brain. In this manner, Matsuda et al. demonstrated
that oral glucose ingestion produced a profound transient
reduction in hypothalamic BOLD fMRI signal in lean
subjects [18]. They alluded to the hypothalamic eﬀects
being mediated by neurohumoral factors following glucose
ingestion, since the hypothalamic signal change preceded any
significant rise in blood glucose.
In 2000, Liu et al. described a new technique called time
clustering analysis (TCA), whereby the number of voxels
reaching maximum signal intensity as a function of time was
examined [19]. In this way, TCA records the time windows
in which maximal brain responses occur and from which
ROI analysis can be appropriately extracted. By scanning a
1 cm midsagittal slice, they were able to further concentrate
resolution on the hypothalamus and found that significant
hypothalamic deactivation occurred 10 minutes following
glucose ingestion. They also showed that the degree to
which the hypothalamic signal reduced postglucose ingestion
negatively correlated with fasting plasma insulin levels.
Using functional MRI in a 1 cm midsagittal slice,
Smeets and colleagues reported on resting state intrasubject
hypothalamic response before and after ingestion of glucose.
In their original experiment, they also found a dose-
dependent decrease in hypothalamic BOLD fMRI signal in
lean, healthy subjects shortly after ingesting glucose solution,
which lasted for 30 minutes [20]. Using the same experimen-
tal paradigm, they went on to show that hypothalamic BOLD
signal did not decrease following ingestion of an equally
sweet (but calorie deficient) solution of aspartame, or inges-
tion of an equally calorific (but not sweet) solution of mal-
todextrose. They thereby inferred that hypothalamic activity
was specifically glucose-sensitive and that a hypothalamic
response required both sweet taste and energy content [21].
Interestingly, from a clinical perspective, they subsequently
demonstrated that the reduction in hypothalamic BOLD
signal following glucose ingestion was absent in patients with
type 2 diabetes, theorising that inappropriate hypothalamic
processing of nutrient availability may be involved in the
aetiology of the disease [22]. Using the same hypothalamic
BOLD imaging technique as these previous studies, this
group has also alluded to the eﬀects of gut hormones on
hypothalamic activity following glucose ingestion. In healthy
men, despite causing a threefold lower rise in blood glucose
concentration than intravenous glucose administration, oral
glucose ingestion led to a much more robust reduction
hypothalamic BOLD signal [23]. As well as the eﬀect of
taste, it was postulated that hormones such as GLP-1,
released in response to nutrients entering the gut, accounted
for this greater hypothalamic response to oral rather than
intravenous glucose.
However, in contrast to the above findings, a recent study
by Purnell et al. in 2011 did not detect any signal change
in the hypothalamus in response to either glucose or fruc-
tose infusion in 9 healthy, normal-weight subjects, despite
focussing their image acquisition parameters to optimise
hypothalamic signal capture by mid-sagittal T1 weighting
[24]. The authors postulated that diﬀerential activation of
excitatory and inhibitory nuclei within the hypothalamus
may have cancelled out any overall signal change. This
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illustrates the ongoing limitations when attempting to
visualise the human hypothalamus in fMRI studies.
4. fMRI Studies in Normal-Weight
Subjects Comparing the Response to Food
Cues in the Fasted and Fed States
Before moving into the arena of functional brain imaging
studies to specifically determine the neuroendocrinology of
appetite control, it is useful to look at earlier studies which
examined diﬀerences in brain activity in hunger and satiety.
Such diﬀerences may be attributed to a number of physi-
ological diﬀerences between the fed and fasted state, such
as changes in concentrations of gut-derived neuropeptides
(PYY, GLP-1, ghrelin, CCK, and insulin to name but a
few) and vagal aﬀerents conveying information about gut
distension. These early studies into appetitive behaviour
have led to our understanding of how images of food can
trigger the brain’s reward system and how the motivational
potency of this trigger is greater in the fasted state. On
the whole, these studies complemented earlier work which
utilised PET scanning to assess the eﬀects of hunger and
satiety on regional cerebral blood flow diﬀerences and which
particularly implicated the OFC as a critical convergence
zone for sensory information related to rewarding stimuli
[25–28].
Most of these fMRI studies have been task-based sub-
traction analyses, looking at diﬀerences in regional brain
activation between when viewing images of food or nonfood
items. It is well understood that, whilst taste provides an
immediate reward (or punishment) for consumed foods, the
visual characteristics of food are quickly learned and become
powerful secondary reinforcers, capable of influencing sub-
sequent food-seeking behaviour. Thus, showing food images
is a useful way of examining the appetitive reward circuitry.
In the first study of its kind in 2001, LaBar et al. reported
on 9 healthy subjects, who underwent an initial whole-brain
fMRI after an 8 hour fast, followed by another postmeal
scan one hour later. A follow-up study was performed on
8 subjects who were fed a meal before the first of the two
scans to rule out the potential of habituation eﬀects in
the first group. The subjects were presented with food and
nonfood images during each scan and subtraction analysis
was performed [29]. The authors’ hypothesis that variation
in the state of hunger would modulate the response of the
amygdala and anatomically related corticolimbic structures
was borne out in a ROI analysis, which revealed satiety-
induced reduction in activity in the amygdala, parahip-
pocampal gyrus, and fusiform gyrus. They suggested that
the amygdala, with its extensive neural connections with the
hypothalamus and higher brain centres, was in a pivotal
position for integrating response to visual food stimuli in the
context of nutritional status. However, it was noted that this
study was underpowered to detect similar satiety-induced
changes in many other ROIs studied.
In 2003, Killgore et al. used a diﬀerent approach by
scanning satiated recruits who were presented with pictures
of high calorie, low calorie, and nonfood items. Irrespective
of calorific content, food images caused greater activation
than nonfood images in the amygdala, hippocampus, and
ventromedial prefrontal cortex [30]. The authors point
out the importance of these areas in the expectation and
evaluation of reward. High-calorie foods caused particular
activation of the medial and dorsolateral prefrontal cortex,
understood to be involved in evaluating stimulus relevance
within the current aﬀective state of the individual. In
contrast, low calorie foods resulted in lesser activation
of these reward areas per se and greater activation in
somatosensory areas, with a suggestion from the authors
that this was due to a lesser cephalic phase response by
classical conditioning to images of less appealing foods. In
2005, Killgore published a reanalysis of this study data, using
an ROI approach (specifically, a subanalysis of the OFC)
and correlated BOLD activity with BMI. It was reported
that, for the high calorie minus nonfood contrast, there was
a significant negative correlation between BMI and BOLD
signal in the OFC [31]. In other words, as BMI increases,
activity in the OFC becomes less food responsive. This
highlights the more subtle role of parts of the OFC not
just in simply assigning reward value to certain stimuli, but
in modifying stimulus-reward associations and accordingly
redirecting feeding-related behaviour in response to new
learning [32]. Of course, in this particular study, it was not
possible to extend these findings to the obese population,
since the subjects studied were all within the normal weight
range.
In 2005, St-Onge et al. published the only fMRI study to
date where fasted individuals were exposed to four diﬀerent
stimuli: visual food, visual nonfood, tactile food, and tactile
nonfood. In an uncorrected whole brain analysis, they
reported that the anterior cingulate, superior temporal gyrus,
hippocampus, and insula were significantly activated to a
greater extent during the presentation of foods (whether seen
or felt) over nonfood items [33].
In 2006, Porubska´ et al. published the results of an
fMRI study of 12 normal-weight fasted subjects. Visual food
stimuli (in contrast to nonfood images) activated the insular
and orbitofrontal cortices, with a positive modulation of
insular activity induced by subjective ratings of appetite
[34]. These findings are consistent with the recognition
of the insula as being an important region in establishing
salience [35]. Following on from this, Fu¨hrer et al. in 2008
studied 12 healthy male volunteers undergoing two separate
scanning sessions—one when fasted overnight and the other
immediately after a large meal. They performed a whole
brain, uncorrected analysis of the data and particularly
noted significantly enhanced activity within the OFC when
hungry, again with reference to our understanding of this
area as subjectifying the perceived pleasantness of food [36].
We have also recently demonstrated that feeding reduces
the diﬀerence in BOLD signal between viewing images of
food and nonfood in several brain regions (Figure 3), but
significantly so in the insula [37]. Furthermore, in 2009,
Goldstone et al. reported the findings from a fMRI study
of twenty individuals in both the fed and fasted state;
subjects viewed pictures of high calorie, low calorie, and
nonfood items whilst rating the appeal value of these images.
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Figure 3: Modulation of neuronal activity in the fed versus fasted
state. Representative whole-brain fMRI sections showing regions
where the diﬀerence in BOLD signal between viewing food images
and nonfood images is blunted in the fed state compared with the
fasted state. Unpublished image from [37].
They found that when fasted, there was significantly greater
activation to high calorie over low calorie food items in
the ventral striatum (important in mediating hedonic drive
and action [38]), amygdala, anterior insula, and OFC. They
found that high calorie foods were consistently rated as more
appealing, that this was augmented with fasting and that
the increase in appeal rating bias for high calorie over low
calorie foods in the fasted state was positively correlated
with activity in the OFC [39]. In the same year, Schur et al.
performed a study of ten normal weight, fed subjects
viewing images of fattening food, nonfattening food, and
nonfood items. These food images were specifically chosen
based on whether the food was perceived to be compatible
with an eﬀort to lose weight. In a ROI analysis, this was
the first study to report increased hypothalamic activation
when viewing pictures of fattening food compared with
nonfood items, although this finding did not extend to other
comparisons (i.e., fattening versus nonfattening or all food
versus nonfood). In concordance with other studies, they
also found increased activation in the amygdala, insula and
OFC when viewing fattening foods compared with nonfood
items [40]. Also in agreement with previous findings were the
results of Siep et al., who in 2009 reported increased activity
in the amygdala and OFC in response to viewing high calorie
versus low calorie food images, but only when their subjects
were fasted [41]. Their experimental protocol allowed for
the further observation that this increased activity in the
amygdala and OFC was only evident when participants
explicitly evaluated foods but not when their concentration
was diverted elsewhere.
5. Differing fMRI Responses in Obesity
Bearing in mind the results of the above studies in normal
weight individuals, it is now interesting to turn to the
results of similar studies comparing obese and normal weight
subjects.
As discussed above, in 1999, Matsuda et al. studied
the hypothalamic response before and after oral glucose
ingestion. Although they showed that oral glucose ingestion
produced a profound transient reduction in hypothalamic
signal in 10 lean subjects, this response was both significantly
delayed and attenuated in 10 obese individuals. More
tellingly, it was shown that, following glucose ingestion, the
time taken to reach the maximum hypothalamic inhibitory
response was closely correlated to fasting plasma glucose and
insulin levels (which, as expected, were significantly higher
in the obese group) rather than BMI per se, suggesting
hypothalamic dysfunction as either the cause or consequence
of insulin resistance [18].
To extend the above findings to the study of reward
regions, a later study incorporating visual food and nonfood
cue methodology revealed that BOLD fMRI activation in the
right hippocampus (with respect to high calorie food images
versus other images) correlated positively with fasting insulin
levels and waist circumference (but not BMI) in 12 normal
weight and 12 obese adolescents who had all been fed a
standard breakfast a few hours prior to scanning [42]. On
the other hand, in that study, there was significant negative
correlation between activation of the medial right superior
frontal gyrus and the left thalamus (again, with respect to
the contrast between high calorie food images versus other
images) with fasting insulin levels. The authors postulated
that their results reflected a permissive role of insulin in the
control of eating behaviour by the hippocampus. We further
speculate that, in those with a larger waist circumference and
high circulating levels of insulin (i.e., peripherally insulin
resistant individuals), a degree of central insulin resistance in
the hippocampus may explain the greater activation in this
region, despite higher insulin levels.
Studies investigating the diﬀerential reward system acti-
vation patterns when looking at high calorie foods between
obese and normal weight subjects have shown significantly
greater activation in the obese group in several brain regions
implicated in food reward. In a study by Rothemund et al.
in 2007 of 13 obese and 13 normal weight women who
had been fasted for at least 90 minutes, increasing BMI
positively predicted BOLD activation of the dorsal striatum
(caudate/putamen), anterior insula, claustrum, posterior
cingulate, postcentral cortex, and lateral OFC. This specifi-
cally pertained to the contrast between viewing high calorie
food images versus nonfood images [43]. A further ROI-
based study by Stoeckel et al. in 12 obese and 12 normal
weight women demonstrated that pictures of high calorie
foods (versus nonfood) produced greater activation in
the obese group compared with controls in several brain
regions, including the ventral and dorsal striatum, insula,
anterior cingulate cortex, amygdala, OFC, hippocampus,
ventral pallidum, and medial prefrontal cortex [44]. A
further functional connectivity analysis indicated that obese
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women displayed a relative deficiency in the amygdala’s
modulation of the OFC and ventral striatum, along with
excessive modulation of the ventral striatum by the OFC
[45]. Collectively, results from the above studies suggest that
a hyperreactive reward system to high calorie food cues is
involved in the pathophysiology of obesity.
Fascinatingly, several studies have shown that obese
individuals respond diﬀerently to satiation compared with
normal weight individuals, which allows us to hypothesize
that, in obesity, there is a degree of dysregulation in CNS
appetite regions, which may contribute to overeating and
hence weight gain.
A ROI-based study by Martin et al. measured fMRI
BOLD activation pre- and postprandially (following a 500
kCal meal) in response to pictures of food (a combination of
high calorie and low calorie images) and nonfood in 10 obese
and 10 healthy weight adults. During the premeal condition,
obese subjects showed increased activation in the anterior
cingulate and medial prefrontal cortex, compared to healthy
weight controls [46], thus concurring with the observations
of Stoeckel et al. During the postmeal condition, obese
participants also showed greater BOLD activation in the
medial prefrontal cortex compared with healthy weight
controls. A further recent study by Dimitropoulos et al. of 22
overweight/obese males and 16 normal weight males showed
that before eating, obese subjects showed greater response to
food images (versus nonfood images) compared with normal
weight subjects in the anterior prefrontal regions [47].
Postprandially, the obese group demonstrated increased
response to all food images (versus nonfood) compared
with normal weight individuals in frontal, temporal, and
limbic regions. Specific greater activation to high calorie
foods was seen in the obese group compared with normal
weight individuals in the lateral OFC, caudate, and anterior
cingulate cortex [47].
An interesting hypothesis to explain abnormal eating in
obesity was postulated by Stice et al., following an fMRI
study in 2008. Here, a comparison was made between brain
activity in 7 obese and 11 lean adolescent girls during the
anticipated receipt of chocolate milkshake, during actual
receipt of the milkshake, during anticipated receipt of a
tasteless control solution, and during actual receipt of the
tasteless control solution. In response to anticipated receipt
and actual receipt of the chocolate milkshake (versus the
tasteless solution), obese adolescent girls showed greater
BOLD activation bilaterally in the anterior and mid insula,
frontal operculum, parietal operculum, and rolandic oper-
culum compared with lean adolescent girls. However, the
obese girls displayed lower BOLD activation in the caudate in
response to actual consumption of the milkshake (versus the
tasteless solution) compared with the lean girls. From these
results, the authors suggested that obese individuals show
greater salience-associated responses from anticipated food
consumption in gustatory and somatosensory regions, but
weaker activation in the caudate during actual consumption
compared to lean individuals [48]. They further postulated
that this reflects increased anticipatory food reward (but
reduced consummatory food reward) in obesity, which may
contribute to overeating. In a further study, after baseline
characterisation, 8 women who showed >2.5% increase in
BMI over a 6-month period showed reduced striatal BOLD
fMRI response to chocolate milkshake consumption (versus
a tasteless control solution) compared with 12 women who
demonstrated stable weight [49]. These results reinforced
the authors’ hypothesis that weight gain may be associated
with reduced sensitivity of striatal reward circuitry (probably
due to the downregulation of dopamine D2 receptors),
which may be a fundamental mechanism responsible for
overeating.
Diﬀerences between normal weight and obese indi-
viduals have been replicated in studies of children; in
one such investigation of 10 obese and 10 normal weight
children, in the fasted state, the obese group showed greater
BOLD activation (when viewing food images versus nonfood
images) in the prefrontal cortex compared with the normal
weight group. Following a meal, the reduction in activation
of the prefrontal cortex and nucleus accumbens was blunted
in the obese group. Furthermore, the postmeal activation of
the OFC (to food versus nonfood images) was greater in the
obese group compared with the normal weight group [50].
6. fMRI Studies of Hormones Implicated in
Appetite Control
Having discussed the first generation of fMRI studies
exploring the physiological responses to feeding, followed by
studies investigating alteration of such responses in obese
individuals, we will now direct our focus to research that
has investigated the eﬀects of appetite modulating hormones
derived from the gastrointestinal tract and adipose tissue on
the fMRI neuronal response. As alluded to earlier, such hor-
mones are thought to be key mediators of both short-term
and longer-term energy balance; in the postprandial state,
anorectic hormones (including PYY, GLP-1, and insulin)
predominate, and in the longer-term, high-circulating levels
of leptin and insulin correlate with nutritional status. In
contrast, in the fasted, hungry state, the orexigenic hormone
ghrelin is dominant amongst gut hormones. It is therefore
interesting to observe the eﬀects of exogenous administration
of such hormones on the fMRI response and compare these
results with outcomes from earlier studies comparing the
physiological fasted and fed states. It is worth noting that,
thus far, the majority of fMRI studies coupling the exogenous
administration of appetite modulating hormones (with the
exception of studies of leptin) have been conducted in
healthy, normal weight subjects, in order to investigate the
action of such hormones in normal physiology.
6.1. PYY and GLP-1. PYY and GLP-1 are anorectic hor-
mones, released by the enteroendocrine L cells of the gut
following a meal; they lead to marked inhibition of food
intake when administered to fasted human subjects [51–53].
In healthy human subjects, following intravenous infusion
of PYY3−36, there was not only reduced food intake, but
increased activity in the hypothalamus and OFC, as assessed
by BOLD fMRI [15]. This study was conducted with subjects
at rest, without engagement in a visual food-cue-based
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task. Furthermore, during saline infusion visits, subjects’
caloric intake correlated positively with BOLD signal change
in the hypothalamus, whereas this switched to a negative
correlation between caloric intake and OFC signal on study
visits when PYY3−36 was infused. It was postulated that the
presence of PYY3−36 switched regulation of food intake from
a homeostatic brain region (hypothalamus) to a hedonic
region (OFC).
Using a visual food-cue-activated BOLD fMRI method,
we recently investigated the eﬀects of PYY3−36 and GLP-
17−36amide on neuronal activity in brain regions contributing
to appetitive processing and behaviour [37]. We scanned
15 healthy, lean subjects on five separate occasions, during
which they each received the following interventions in
randomised order after an overnight fast: a saline infusion;
a saline infusion following a large breakfast; an infusion
of PYY3−36; an infusion of GLP-1; a combined infusion of
PYY3−36 + GLP-1. Combined infusion of the gut hormones
reduced ad libitum energy intake at a subsequent buﬀet
meal to a similar degree as on the day when subjects
received breakfast without either gut hormone. Notably,
the BOLD fMRI signal change (comparing exposure to
food images versus nonfood images) in several a priori
brain ROIs was reduced following consumption of breakfast
(Figure 3) and also when the gut hormones were infused
in the fasted state. The largest reduction in BOLD signal
occurred in the insula with combined administration of
PYY3−36 and GLP-1, although we detected smaller reductions
following feeding and gut hormone administration (either
singly or in combination) in the striatum and OFC. Of
note, our image acquisition parameters were not designed to
optimise hypothalamic capture in favour of reward regions.
Furthermore, when comparing our results for the OFC with
those of Batterham et al., it must be remembered that a direct
comparison between studies is diﬃcult due to the method-
ological diﬀerences between them. Nevertheless, our study
concluded that combined administration of the anorectic
gut hormones PYY3−36 and GLP-1 to fasted individuals
was associated with brain activation and subsequent eating
behaviour changes similar to those after eating a full meal,
thereby reinforcing the view that PYY and GLP-1 are key
mediators of postprandial satiety.
6.2. Ghrelin. Ghrelin is a potent orexigenic gut hormone
released from the stomach in response to fasting; adminis-
tration of ghrelin to humans increases food intake [54]. A
study by Malik et al. demonstrated that in normal-weight
human subjects, intravenous ghrelin infusion increased
hunger ratings and also increased the BOLD fMRI signal
change (between food and nonfood visual cues) compared
with saline infusion in the amygdala, OFC, insula, visual
areas, and striatum [55]. The fMRI methodology used in
this study was similar to that used in our PYY and GLP-1
investigation, so it is interesting to compare the results;
whereas the anorectic hormones PYY and GLP-1 reduced
BOLD signal in reward regions, the action of the orexigenic
hormone ghrelin did the reverse, presumably in keeping with
the opposing physiological roles of these peptides.
6.3. Insulin. Insulin has a central anorectic eﬀect in normal
physiology [56]. This must be distinguished from the
secondary eﬀect of hunger resulting from hypoglycaemia
that may follow the exogenous administration of insulin
(the associated overcompensatory eating may provide some
explanation as to why patients with diabetes treated with
insulin tend to gain weight). Therefore, human studies
investigating the direct physiological action of insulin in the
CNS have had to overcome the hurdle of maintaining eug-
lycaemia during insulin administration, for otherwise, it is
the eﬀect of hypoglycaemia (rather than the eﬀect of insulin
per se) that would manifest. Furthermore, to eﬀectively
study the action of insulin in the CNS, peripheral eﬀects of
the hormone should ideally be eliminated, hence even the
use of a euglycaemic hyperinsulinaemic clamp technique is
unsatisfactory in this regard. One group has used intranasal
insulin administration as a method of overcoming this
technical diﬃculty, demonstrating that insulin resulted in
reduced BOLD fMRI activation (with respect to food images
versus nonfood images) in 9 healthy, normal-weight adults
compared with placebo in the right and left fusiform gyrus,
the right hippocampus, right temporal superior cortex, and
the right frontal middle cortex [57]. Notably, peripheral
plasma glucose did not change following the intranasal
insulin administration, thus validating their technique of
observing the central eﬀects of insulin.
6.4. Leptin. Leptin-deficient individuals are obese and
hyperphagic; replacement of leptin in these individuals
reduces food intake [58]. However, the well-recognised
phenomenon of leptin resistance in obesity has precluded
its development from a therapeutic viewpoint. fMRI studies
of leptin administration are nevertheless interesting to shed
further light on the physiological regulation of appetite.
In 2 congenitally leptin deficient human subjects, daily
subcutaneous leptin replacement reduced BOLD fMRI acti-
vation (in terms of the diﬀerence in activation between view-
ing food and nonfood images) in the nucleus accumbens-
caudate and putamen-globus pallidus regions compared
with the control, leptin-deficient state. Furthermore, before
leptin treatment, activation in the nucleus accumbens-
caudate correlated positively with liking of food images in
both the fed and fasted states, whereas, after leptin treatment,
activation in the nucleus accumbens-caudate correlated pos-
itively with liking of food images only in the fasted state [59].
Another study that year demonstrated that, in 3 congenitally
leptin deficient human subjects, daily subcutaneous leptin
replacement reduced the diﬀerence in BOLD fMRI activation
(between viewing high-calorie and low-calorie food images)
in regions implicated in the insula, temporal and parietal
cortex compared with when subjects were not receiving
leptin. On the other hand, leptin replacement increased the
diﬀerence in BOLD fMRI activation (between viewing high-
calorie and low-calorie food images) in the prefrontal cortex
compared with when subjects were not receiving leptin [60].
The authors postulated that the insula, temporal cortex, and
parietal cortex are hunger regions and therefore are inhibited
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Figure 4: Modulation of the rewarding aspects of food. In this highly simplified schematic, the orbitofrontal cortex (OFC) is highlighted
as the most important hub in the reward encoding network. External food cues, via the visual cortex (VC), modulate the OFC response,
with increased activity seen in fasted and obese patients and in response to high- versus low-calorie foods. OFC activity is also thought to
be modulated by inputs from the hypothalamus, which senses internal information about nutritional status in the form of adiposity signals
(such as leptin, which gives information about longer-term energy stores) and gut hormones (which are meal dependent and therefore
give information about shorter-term nutrient availability). Anorectic (postprandial) gut hormones, such as PYY and GLP-1, attenuate OFC
activity and, in fasted individuals induce, an OFC response to visual food cues more similar to that measured when fed. Conversely, the
orexigenic hormone ghrelin upregulates reward centre activity.
by leptin, whereas the prefrontal cortex is a satiety region and
is thus inhibited by weight loss and activated by leptin.
Following this, a study by Rosenbaum et al. in 2008
showed that in 6 leptin replete obese human subjects who
achieved an initial 10% weight loss (between 36 and 62
days) through dietary means, there was increased BOLD
fMRI signal diﬀerence (between comparing food images and
nonfood images) in several regions including the brainstem
and parahippocampal gyrus compared with the baseline
state before weight loss. These changes were reversed by 5
weeks of subcutaneous leptin administration. Interestingly,
other regions, including the hypothalamus and cingulate
gyrus responded in the opposite direction following weight
loss, but these changes remained sensitive to reversal by 5
weeks of subcutaneous leptin administration [61]. This study
reinforced the idea that weight loss leads to a state of relative
leptin deficiency, which may be responsible for the rebound
hyperphagia and subsequent weight gain in many dieters.
Figure 4 shows a simplified schematic of the modulation
of appetite centres by peripheral signals via the hypothala-
mus and in obesity.
7. Imaging before and after Gastric
Bypass Surgery
The most eﬀective treatment for obesity available at present
is Roux-en-Y gastric bypass surgery, leading to sustained
weight loss of approximately 30% and often a very prompt
resolution of type 2 diabetes [62].
Although the mechanisms behind the weight loss seen
following Roux-en-Y bypass surgery remain to be fully
elucidated, they are unlikely to be solely due to restrictive
or malabsorptive means alone. Roux-en-Y results in greater
weight loss than adjustable gastric banding, and this is
thought to be due to a number of additional neurohormonal
causes [63]. These include elevated postoperative levels of
endogenous anorectic gut hormones such as PYY and GLP-1
[64–66], increases in energy expenditure and metabolic rate
[67], changes in taste preference away from calorie dense
foods [68, 69], increased bile acid delivery to the ileum [70],
and changes in gut microbiota [71]. Recent studies imaging
appetite in patients before and after weight loss are important
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in helping us to understand some of the CNS-mediated
eﬀects.
In 2011, Van De Sande-Lee performed fMRI studies on
8 lean control subjects and 13 obese patients before- and
after- Roux-en-Y gastric bypass, by which an average 30%
reduction in body weight had been achieved [72]. They
replicated the TCA experiment described earlier [19]. In
addition, they also performed a functional connectivity anal-
ysis. Their TCA findings mirrored that found previously—
namely that the reduction in hypothalamic signal seen 5–
10 minutes following glucose ingestion in normal controls
was diminished in the obese (preoperative) group. However,
a recovery of this impaired hypothalamic response was
seen postoperatively when the obese group had lost weight
following gastric bypass surgery. Interestingly, they also
reported, in lean subjects, a high level of functional connec-
tivity between the hypothalamus and the orbitofrontal and
somatosensory cortices. This was not seen in obese subjects,
but postoperative weight loss was reported to re-establish
these connectivity patterns [72].
In the same year, a further ROI-based study of 10
obese female patients 1 month before- and after- Roux-
en-Y gastric bypass, there was attenuation of fMRI BOLD
signal (when viewing high-calorie versus low-calorie food
images) in the ventral tegmental area, ventral striatum,
putamen, lentiform nucleus, posterior cingulated, and dor-
somedial prefrontal cortex following the bypass procedure
[73]. In this study, hunger was also reduced after surgery.
Although circulating gut hormone levels were not measured,
the authors speculated that postsurgical reductions in the
orexigenic hormone ghrelin could have explained their
imaging observations. This would certainly be consistent
with the previous fMRI findings byMalik et al. [55] following
exogenous ghrelin administration. Equally, it is possible
that elevated levels of PYY and GLP-1 after-bypass would
explain the imaging findings, consistent with our recent
fMRI findings [37] following exogenous administration of
these anorectic hormones. Indeed, the elevation in PYY and
GLP-1 levels achieved in our study following exogenous
administration of the hormones was similar to the elevated
endogenous levels of PYY and GLP-1 observed in previous
studies following gastric bypass surgery [65]. These findings
are striking, given the need to develop nonsurgical solutions
for the treatment of obesity. To date, all centrally acting drugs
developed to treat obesity have failed due to cardiovascular
and mood altering side eﬀects, as a result of actions
outside pathways solely governing appetite. Therefore, it is
foreseeable that, in the future, elevating circulating levels of
PYY and GLP-1 (by means of exogenous administration)
to similar levels as found naturally after a gastric bypass
procedure may represent a novel pharmacological method of
treating obesity.
8. Conclusion
The use of fMRI to study appetite control in humans is
a rapidly evolving field. There appears to be a degree of
consistency between studies, suggesting that, in the fasted
state, greater BOLD activation is seen in several brain
regions implicated in reward processing when food cues
(and in particular high calorie food cues) are presented to
subjects. Obese subjects seem to show heightened response
to such food cues, which may fundamentally contribute to
increased wanting of food (and thus increased subsequent
food intake) in obese individuals. The fMRI data also seems
to be in agreement that the consumption of a meal (or
other surrogate markers of feeding, such as a rise in glucose)
tends to deactivate key appetite regions in normal weight
individuals and, furthermore, that this satiety response may
also be abnormal in those with obesity. Further studies
should lead to consolidation of existing concepts on the role
of individual brain regions and their interconnections in
physiological and pathological satiety responses.
Building on this fundamental understanding of the
change in BOLD signal between the fasted and fed states,
recent studies have suggested that, in general, orexigenic sig-
nals, which are in abundance in the fasted state, increase the
BOLD response in brain reward regions, whereas anorectic
signals, which predominate in the fed state, correspondingly
deactivate the same regions. Subtle diﬀerences in brain
responses between these studies may reflect the slightly
diﬀerent roles of the diﬀerent hormonal signals in short-
term versus longer-tem energy homeostasis and also may
reflect diﬀerential action on various appetite pathways.
Nevertheless, studies in obese patients, assessing the eﬀect
of gastric bypass surgery on the fMRI BOLD response, have
further concurred with the results of studies investigating the
BOLD response following the exogenous administration of
orexigenic and anorectic hormones, thus consolidating the
overall body of work in the area.
Although fMRI is at present used only as a research tool
to study appetite, the overall goal in the future will be to
translate this research into the clinical arena. An obvious
role would be to help develop pharmacological treatments
for obesity, by means of assessing the fMRI response to
administration of novel agents in obese individuals. Alter-
natively, we may envisage the use of fMRI as a tool to help
predict response to gastric bypass surgery. To aid eﬀective
comparison of results, it would be enormously useful to
strive towards greater consistency between studies, particu-
larly with regard to experimental design, image acquisition
and image analysis. The studies outlined in this paper have
established key concepts, and it is expected that the coming
decade should see consolidation of these findings. We are
fortunate that functional MRI studies have allowed scientists
to investigate for the first time in humans, the intricacies
of appetitive processing. As this technology continues to
evolve, it will remain an important tool for investigating basic
physiology as well as evaluating new therapies.
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